Carolina A Isnardi, Karen Roberts, Verónica Saurit, Ingrid Petkovic, Roberto M Báez, Rosana Quintana, Yohana Tissera, Sofía Ornella, Maria Eugenia D Angelo Exeni, Cecilia N Pisoni, Vanessa V Castro Coello, Guillermo Berbotto, María J Haye Salinas, Edson Velozo, Álvaro A Reyes Torres, Romina Tanten, Marcos D Zelaya, Carla Gobbi, Carla G Alonso, María de Los Ángeles Severina, Florencia Vivero, Alba Paula, Adriana K Cogo, Gelsomina Alle, Mariana Pera, Romina E Nieto, Micaela Cosatti, Cecilia Asnal, Dora Pereira, Juan A Albiero, Verónica G Savio, Federico N Maldonado, María Julieta Gamba, Noelia F Germán, Andrea Baños, Josefina Gallino Yanzi, María Soledad Gálvez Elkin, Julieta S Morbiducci, María Victoria Martire, Hernán Maldonado Ficco, Maria Marcela Schmid, Jaime A Villafañe Torres, Maria de Los Ángeles Correa, María Alejandra Medina, María Alejandra Cusa, Julia Scafati, Santiago E Agüero, Nicolás M Lloves Schenone, Enrique R Soriano, Cesar Graf, Bernardo A Pons-Estel, Gimena Gomez, Margarita Landi, María Celina De la Vega, Guillermo J Pons-Estel
BACKGROUND/OBJECTIVE: This study aims to describe the course and to identify poor prognostic factors of SARS-CoV-2 infection in patients with rheumatic diseases. METHODS: Patients ≥ 18 years of age, with a rheumatic disease, who had confirmed SARS-CoV-2 infection were consecutively included by major rheumatology centers from Argentina, in the national, observational SAR-COVID registry between August 13, 2020 and July 31, 2021. Hospitalization, oxygen requirement, and death were considered poor COVID-19 outcomes...
October 6, 2022: Clinical Rheumatology